Black Rock Inc. Bright Minds Biosciences Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
About BRIGHT MINDS BIOSCIENCES INC.
- Ticker DRUG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,209,900
- Market Cap $709M
- Description
- Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collabor...